Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HIV protease (also known as HIV-1 protease or PR) is a retroviral aspartyl protease that plays an essential role in the life cycle of the Human Immunodeficiency Virus (HIV), which causes AIDS. It is responsible for cleaving newly synthesized polyproteins—specifically Gag and Gag-Pol—at nine distinct sites, producing the mature protein components required for assembling infectious viral particles. Without functional HIV protease, new virions remain immature and non-infectious.
Competitive inhibition of HIV protease active site, preventing polyprotein cleavage.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HIV Protease (PR).